
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. I’m back from my three-week vacation. No big news happened while I was gone, right?
Well, we’ve got a lot of news this morning, so let’s get into it.

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in